TY  - JOUR
AU  - Puig, Ignasi
AU  - Gonzalez-Santiago, Jesus M.
AU  - Molina-Infante, Javier
AU  - Barrio, Jesus
AU  - Teresa Herranz, Maria
AU  - Algaba, Alicia
AU  - Castro, Manuel
AU  - Gisbert, Javier P.
AU  - Calvet, Xavier
PY  - 2017
DO  - 10.1111/ijcp.13004
SN  - 1368-5031
UR  - http://hdl.handle.net/10668/18989
T2  - International journal of clinical practice
AB  - IntroductionThe efficacy of currently recommended third-line therapies for Helicobacter pylori is suboptimal, even that of culture-guided treatments. Resistance to multiple antibiotics is the major factor related to treatment failure. The aim of this...
LA  - en
PB  - Wiley
KW  - amoxicillin
KW  - esomeprazole
KW  - Helicobacter pylori
KW  - metronidazole
KW  - rescue treatment
KW  - third-line treatment
KW  - Triple therapy
KW  - Rescue therapy
KW  - Quadruple therapy
KW  - Pump inhibitors
KW  - Levofloxacin
KW  - Eradication
KW  - Efficacy
KW  - Metaanalysis
KW  - Rifabutin
KW  - Bismuth
TI  - Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infection
TY  - research article
VL  - 71
ER  -